| Line Item | 2022-09-24 | Y/Y |
|---|---|---|
| Revenue | $593.3M | +135.5% |
| Cost of Revenue | $493.7M | +104.4% |
| Gross Profit | $99.6M | +853.8% |
| R&D Expense | $124.1M | +69.2% |
| SG&A Expense | $115.9M | +94.9% |
| Operating Income | -$140.4M | -14.7% |
| Pre-tax Income | -$139.1M | -13.7% |
| Income Tax | $0 | — |
| Net Income | -$72.1M |
| Line Item | 2022-09-24 | Y/Y |
|---|---|---|
| Cash & Equivalents | $353.5M | +125.7% |
| Accounts Receivable | $3.4M | -94.6% |
| Inventory | $91.9M | +173.8% |
| Current Assets | $605.4M | +132.5% |
| Total Assets | $631.3M | +125.0% |
| Current Liabilities | $523.0M | +55.2% |
| Total Liabilities | $562.3M | +0.9% |
| Line Item | 2022-09-24 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$148.2M | -235.3% |
| Capital Expenditures | $17.9M | +47.5% |
| Investing Cash Flow | -$17.9M | -47.5% |
| Financing Cash Flow | $362.4M | — |
| Free Cash Flow | -$166.2M | -270.6% |
| +41.0% |
| EPS (Basic) | -$0.13 | — |
| EPS (Diluted) | -$0.13 | — |
| Stockholders' Equity |
| $7.2M |
| +159.6% |